leads the oral GLP-1 market due to a large diabetic and obese population, strong R&D capabilities, and rapid adoption of innovative therapies like oral semaglutide
It shows up in news headlines, social media discussions, and conversations with friends who've started treatment
Safety Monitoring and Adverse Event Management Hers providers conduct baseline screening for contraindications and advise patients on common GLP-1 side effects including nausea, vomiting, constipation, and rare pancreatitis risk
It reduces oxidative stress, which is essential for shielding nerve cells from harm caused by neurological conditions (6)
[105] This trial enrolled 14,752 patients (73.1% of whom had preexisting CVD) who were randomly assigned to receive exenatide once weekly or placebo for a median of 3.2 years